The "Oncology Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.

The global oncology drugs market is expected to reach around $150 billion in 2020

The oncology drugs market is expected to grow due to the increasing number of expensive but advanced and effective medications that will help in increasing the life expectancy of cancer patients. For example, in 2017, Kite Pharma's CAT-T cell therapy, under clinical trial, showed results of increased life expectancy of terminally ill lymphoma patients by 9 months after a single treatment.

Collaboration Driving Innovation - Companies in the oncology drug market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive oncology drug market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as academic and research institutions in this market by striking partnering, in or out licensing deals, this trend may have increased in recent years.

For instance, in January 2016, AstraZeneca and Moderna Therapeutics entered into a collaboration to discover, co-develop and co-commercialize immuno-oncology mRNA therapeutics for the treatment of cardiovascular, metabolic and renal diseases as well as selected targets in oncology. Servier and Novartis have also extended their collaboration to co-develop and commercialize anti-Mcl-1 drug candidates for cancer treatment.

Global Oncology Drugs Market Split By Segments

  • Blood Cancer
  • Breast Cancer
  • Cervical Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Non-Small Cell Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Gastric Cancer
  • Brain Tumor
  • Pancreatic Cancer
  • Skin Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Others

Oncology Drugs Market Competitive Landscape

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Bayer AG
  • Takeda Pharmaceuticals
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co., Ltd.
  • Boehringer Ingelheim GmbH
  • Eli Lilly And Company
  • Pfizer Inc.
  • F.Hoffmann-La Roche
  • Novartis
  • Gilead Sciences, Inc.

Oncology Drugs Market Key Mergers And Acquisitions

  • Novartis Acquired GSK's Oncology
  • Pfizer Acquired Medivation
  • Takeda Pharmaceutical Company Acquires ARIAD Pharmaceuticals, Inc.
  • Roche Acquired Seragon
  • Jazz Pharmaceuticals Acquired Celator
  • Sumitomo Dainippon Pharma Co. Ltd. Acquires Tolero Pharmaceuticals
  • Ipsen Acquires Oncology Assets From Merrimack Pharmaceuticals
  • Celldex Therapeutics Acquires Kolltan Pharmaceuticals
  • Merck Acquired OncoEthix
  • NeoGenomics Acquired Clarient
  • Merger Of Threshold Pharmaceuticals With Molecular Templates, Inc.
  • Definitive Merger Of Achieve Life Science, Inc. By OncoGenex Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/lpdcnc/global_oncology?w=4